Skip to main content
. 2020 Nov 2;12(11):696. doi: 10.3390/toxins12110696

Table 1.

Patient characteristics according to whether baseline PAD was present or not.

Characteristic Overall PAD at Baseline p Value
(n = 234) No
(n = 200)
Yes
(n = 34)
Age (years) 63 ± 13 62 ± 13 69 ± 11 0.007
Male sex, n (%) 128 (54.7%) 109 (54.5%) 19 (55.9%) 0.881
Current smoker, n (%) 27 (11.5%) 22 (11.0%) 5 (14.7%) 0.532
DM, n (%) 103 (44.0%) 74 (37.0%) 29 (85.3%) <0.001
CVD, n (%) 76 (32.5%) 58 (29.0%) 18 (52.9%) 0.006
CAD, n (%) 64 (27.4%) 49 (24.5%) 15 (44.1%) 0.018
Stroke, n (%) 18 (7.7%) 13 (6.5%) 5 (14.7%) 0.097
Dialysis vintage (years) 2.4 (1.4–3.7) 2.4 (1.4–3.7) 2.6 (2.1–4.0) 0.109
BMI (kg/m2) 23.6 ± 3.8 23.6 ± 3.7 23.7 ± 4.1 0.849
ABI 1.06 ± 0.20 1.10 ± 0.16 0.81 ± 0.27 <0.001
Systolic BP (mmHg) 138 ± 20 138 ± 20 136 ± 19 0.533
RAASi, n (%) 75 (32.1%) 64 (32.0%) 11 (32.4%) 0.967
Anti-platelet, n (%) 52 (22.2%) 34 (17.0%) 18 (52.9%) <0.001
Statin, n (%) 35 (15.0%) 22 (11.0%) 13 (38.2%) <0.001
Kt/V 1.8 ± 0.3 1.8 ± 0.3 1.9 ± 0.3 0.318
URR (%) 78.0 ± 5.5 77.8 ± 5.7 78.6 ± 4.9 0.446
nPCR (g/kg/day) 1.1 ± 0.3 1.1 ± 0.3 1.0 ± 0.2 0.103
Hemoglobin (g/dL) 10.5 ± 1.2 10.5 ± 1.2 10.4 ± 1.3 0.893
Albumin (g/dL) 3.9 ± 0.4 3.9 ± 0.4 3.8 ± 0.3 0.170
TC (mg/dL) 158 (136–184) 159 (138–184) 152 (125–192) 0.446
HDL-C (mg/dL) 39 (31–49) 40 (31–50) 35 (27–46) 0.149
LDL-C (mg/dL) 89 (73–107) 91 (73–107) 81 (69–101) 0.142
Triglycerides (mg/dL) 123 (85–193) 126 (86–191) 112 (79–240) 0.942
TC:HDL-C 4.0 (3.0–5.3) 3.9 (3.0–5.4) 4.5 (2.9–5.3) 0.626
Fasting glucose (mg/dL) 98 (87–129) 96 (87–126) 110 (89–150) 0.112
Calcium (mg/dL) 9.3 (8.8–9.8) 9.4 (8.9–9.9) 9.1 (8.8–9.6) 0.140
Phosphate (mg/dL) 4.6 (3.7–5.7) 4.6 (3.8–5.7) 4.2 (3.1–5.7) 0.236
Intact PTH (pg/mL) 265 (126–431) 264 (117–429) 269 (156–436) 0.954
CRP (mg/L) 0.27 (0.12–0.63) 0.27 (0.11–0.59) 0.32 (0.21–0.79) 0.153
Indoxyl sulfate (μg/mL) 45.9 (29.9–62.6) 46.0 (29.7–62.9) 44.4 (30.4–62.2) 0.992

Abbreviations: ABI, ankle-brachial index; BMI, body mass index; BP, blood pressure; CAD, coronary artery disease; CRP, C-reactive protein; CVD, cardiovascular disease; DM, diabetes mellitus; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; nPCR, normalized protein catabolic rate; PAD, peripheral artery disease; PTH, parathyroid hormone; RAASi, renin-angiotensin-aldosterone system inhibitors; TC, total cholesterol; URR, urea reduction rate.